Search Results - "Ross, Nicolette C."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics by Schmid, Cullen L., Kennedy, Nicole M., Ross, Nicolette C., Lovell, Kimberly M., Yue, Zhizhou, Morgenweck, Jenny, Cameron, Michael D., Bannister, Thomas D., Bohn, Laura M.

    Published in Cell (16-11-2017)
    “…Biased agonism has been proposed as a means to separate desirable and adverse drug responses downstream of G protein-coupled receptor (GPCR) targets. Herein,…”
    Get full text
    Journal Article
  2. 2

    Reactive Oxygen and Targeted Antioxidant Administration in Endothelial Cell Mitochondria by O'Malley, Yunxia, Fink, Brian D., Ross, Nicolette C., Prisinzano, Thomas E., Sivitz, William I.

    Published in The Journal of biological chemistry (29-12-2006)
    “…We used fluorescent probes and EPR to study the mechanism(s) underlying reactive oxygen species (ROS) production by endothelial cell mitochondria and the…”
    Get full text
    Journal Article
  3. 3

    Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells by Fink, Brian D, O'Malley, Yunxia, Dake, Brian L, Ross, Nicolette C, Prisinzano, Thomas E, Sivitz, William I

    Published in PloS one (22-01-2009)
    “…Previously, we reported that the "antioxidant" compound "mitoQ" (mitochondrial-targeted ubiquinol/ubiquinone) actually increased superoxide production by…”
    Get full text
    Journal Article
  4. 4

    Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias by Kennedy, Nicole M, Schmid, Cullen L, Ross, Nicolette C, Lovell, Kimberly M, Yue, Zhizhou, Chen, Yen Ting, Cameron, Michael D, Bohn, Laura M, Bannister, Thomas D

    Published in Journal of medicinal chemistry (11-10-2018)
    “…While mu opioid receptor (MOR) agonists are especially effective as broad-spectrum pain relievers, it has been exceptionally difficult to achieve a clear…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Novel opioid cyclic tetrapeptides: Trp isomers of CJ‐15,208 exhibit distinct opioid receptor agonism and short‐acting κ opioid receptor antagonism by Ross, Nicolette C, Reilley, Kate J, Murray, Thomas F, Aldrich, Jane V, McLaughlin, Jay P

    Published in British journal of pharmacology (01-02-2012)
    “…BACKGROUND AND PURPOSE The κ opioid receptor antagonists demonstrate potential for maintaining abstinence from psychostimulant abuse, but existing non‐peptide…”
    Get full text
    Journal Article
  7. 7

    The Macrocyclic Peptide Natural Product CJ-15,208 Is Orally Active and Prevents Reinstatement of Extinguished Cocaine-Seeking Behavior by Aldrich, Jane V, Senadheera, Sanjeewa N, Ross, Nicolette C, Ganno, Michelle L, Eans, Shainnel O, McLaughlin, Jay P

    “…The macrocyclic tetrapeptide natural product CJ-15,208 (cyclo[Phe-d-Pro-Phe-Trp]) exhibited both dose-dependent antinociception and kappa opioid receptor (KOR)…”
    Get full text
    Journal Article
  8. 8

    Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist by Ross, Nicolette C., Kulkarni, Santosh S., McLaughlin, Jay P., Aldrich, Jane V.

    Published in Tetrahedron letters (20-09-2010)
    “…A strategy to select linear precursor peptides favoring cyclization was developed and cyclization conditions were optimized. The tryptophan isomers of the…”
    Get full text
    Journal Article
  9. 9

    Unexpected Opioid Activity Profiles of Analogues of the Novel Peptide Kappa Opioid Receptor Ligand CJ-15,208 by Aldrich, Jane V., Kulkarni, Santosh S., Senadheera, Sanjeewa N., Ross, Nicolette C., Reilley, Kate J., Eans, Shainnel O., Ganno, Michelle L., Murray, Thomas F., McLaughlin, Jay P.

    Published in ChemMedChem (05-09-2011)
    “…An alanine scan was performed on the novel κ opioid receptor (KOR) peptide ligand CJ‐15,208 to determine which residues contribute to the potent in vivo…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Mu Opioid Receptor Agonists with Dopamine D3 Receptor Antagonism: Toward Developing Analgesics with Less Abuse Potential by Shah, Nilay M., Schmid, Cullen L., Merritt, Benjamin, Kennedy, Nicole M., Ross, Nicolette C., Lovell, Kimberly M., Bannister, Thomas D., Bohn, Laura M.

    Published in The FASEB journal (01-04-2018)
    “…Opioid analgesics such as morphine are widely used in clinical practice for the management of moderate to severe pain. While they are the gold standard for…”
    Get full text
    Journal Article
  12. 12

    Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting [kappa] opioid receptor antagonism by Ross, Nicolette C, Reilley, Kate J, Murray, Thomas F, Aldrich, Jane V, McLaughlin, Jay P

    Published in British journal of pharmacology (01-02-2012)
    “…BACKGROUND AND PURPOSE The [kappa] opioid receptor antagonists demonstrate potential for maintaining abstinence from psychostimulant abuse, but existing…”
    Get full text
    Journal Article
  13. 13

    The Macrocyclic Peptide Natural Product CJ-15,208 is Orally Active and Prevents Reinstatement of Extinguished Cocaine Seeking Behavior1 by Aldrich, Jane V., Senadheera, Sanjeewa N., Ross, Nicolette C., Ganno, Michelle L., Eans, Shainnel O., McLaughlin, Jay P.

    “…The macrocyclic tetrapeptide natural product CJ-15,208 ( cyclo [Phe-D-Pro-Phe-Trp]) exhibited both dose-dependent antinociception and kappa opioid receptor…”
    Get full text
    Journal Article